Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 2,157 Jul 31 – Oct 28, 2026
- Disclosed funding
- $147.8B 1464 disclosed amounts
- Median round
- $10M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
Upwind SecurityCompany profile Upwind provides runtime-first cloud security for enterprise security teams. Upwind provides runtime-first cloud security for enterprise security teams. | $400M | Series C final closeSeries C+ | Cybersecurity | United States | Investors | |
AlteonCompany profile Alteon is developing autonomous fixed-wing aircraft for organizations that need persistent aerial observation. Alteon is developing autonomous fixed-wing aircraft for organizations that need persistent aerial observation. | $2.5M | Pre-seed | Mobility | India | Investors | |
| 1I 10pct., Inc.Company profile A hotel operator combining property-management experience with AI software and regional tourism services. A hotel operator combining property-management experience with AI software and regional tourism services. | ~¥400M | Series A | Travel tech | Japan | Investors | |
iPRONICSCompany profile iPRONICS builds silicon-photonics optical circuit switches that let AI data centers reconfigure high-bandwidth connections between compute systems across and within racks. iPRONICS builds silicon-photonics optical circuit switches that let AI data centers reconfigure high-bandwidth connections between compute systems across and within racks. | $125M | Series B | Hardware | Spain | Investors | |
NovaGo TherapeuticsCompany profile NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury. NovaGo Therapeutics is a clinical-stage biotech developing anti-Nogo-A antibodies intended to promote nerve regeneration and functional recovery after central nervous system injury. | CHF 24M | Series B | Biotech | Switzerland | Investors | |
DelfiCompany profile A balance-sheet analytics and decision platform for banks and credit unions, combining risk modeling with financial-product discovery and execution tools. A balance-sheet analytics and decision platform for banks and credit unions, combining risk modeling with financial-product discovery and execution tools. | Undisclosed | Strategic investmentUndisclosed | Fintech | United States | Investors | |
| TC Thyme CareCompany profile Thyme Care combines oncology-trained care teams and technology to support people through cancer treatment while helping health plans and providers improve outcomes and control costs. It monitors patient needs between appointments, coordinates with oncologists and connects members to clinical, practical and social support. Thyme Care combines oncology-trained care teams and technology to support people through cancer treatment while helping health plans and providers improve outcomes and control costs. It monitors patient needs between appointments, coordinates with oncologists and connects members to clinical, practical and social support. | >$125M | Series ESeries C+ | Healthtech | United States | Investors | |
AurenityCompany profile Aurenity is a technology-enabled managing general agent focused on excess-and-surplus insurance. Aurenity is a technology-enabled managing general agent focused on excess-and-surplus insurance. | Undisclosed | Growth investmentGrowth | Fintech | United States | Investors | |
Aslan ProtectsCompany profile A cyber-intelligence platform that deploys human-supervised AI operatives to investigate illicit online spaces for national-security and law-enforcement missions. A cyber-intelligence platform that deploys human-supervised AI operatives to investigate illicit online spaces for national-security and law-enforcement missions. | $20.8M | Seed | Defense tech | United States | Investors | |
Cornerstone RoboticsCompany profile A surgical-robotics company whose Sentire system supports minimally invasive procedures with a multi-arm robot, surgeon console and integrated imaging. A surgical-robotics company whose Sentire system supports minimally invasive procedures with a multi-arm robot, surgeon console and integrated imaging. | $700M | Strategic investmentGrowth | Robotics | Hong Kong | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 31, 2026
- 1Y Combinator (YC)
Vera Health, BioStack, Tractian
69rounds5led - 2Andreessen Horowitz (a16z)
Hex, ASI, Eka Robotics
47rounds18led - 3General Catalyst
Hyperbolic, Re:Build, 22one
35rounds13led - 4Sequoia Capital
Hex, 22one, Nevis
35rounds11led - 5Khosla Ventures
Arda Industries, Tolan
32rounds10led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →